Check AD-218 for fibromyalgia symptoms and safety
Part of Heart & circulation, Hormones & metabolism clinical trials.
This phase 3 study tests whether AD-218 works and is safe for people with fibromyalgia. It may help by improving symptoms, but it also carefully monitors side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 19 years old or older
- Sign and date the informed consent form before joining
- Do not have a past diagnosis of fibromyalgia
- Avoid having muscle disease history such as myopathy
- If you have blood tests, CK (a muscle enzyme) should be less than 2 times the upper normal limit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will compare two versions of a drug (called AD-117 and AD-117A) to see how your body processes them and whether they are safe. You would receive one version and then the other, to compare their effects.
This trial tests two forms of a new medicine to see how safe they are and how the body handles them. It is for healthy adults aged 19 to 64, and participation helps gather important early information before the drug is studied in patients.
This study tests a new medicine called AD-231 and compares it to taking three separate pills together. You would need to be in generally good health and within a certain age and weight range.
This study tests two new drugs in healthy adults to see how safe they are and how the body processes them. Taking part may help researchers learn if the drugs are safe for future use, though there is no direct benefit to you.
This early-phase trial tests a new drug called AD-230 in healthy adults to see how the body absorbs and processes it and to check for safety. You will help researchers learn important information before the drug is tested in patients.
This early-phase trial tests a new investigational drug called AD-230 in healthy adults. The main goal is to understand how the body processes the drug, check its safety, and see how food affects it.
Hear when a new Mixed Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.